fda 503a bulks list bpc-157 category 2 FDA's own advisory committee voted 8-6 Thursday. BPC-157, on the compounding now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them BPC-157 PASSED! Gabriel Alizaidy, MD,
BPC 157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote. It does not immediately make Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for fda category 2 bulk drug substances list bpc 157 Major peptide regulatory news this week. The FDA Removes 12 Peptides from 503A List, PCAC Review to Follow Kurt Lunkwitz posted on the topic LinkedIn
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10